Logo image of VERO

VENUS CONCEPT INC (VERO) Stock Price, Quote, News and Overview

NASDAQ:VERO - Nasdaq - US92332W2044 - Common Stock - Currency: USD

3.15  +2.87 (+1025%)

After market: 3.11 -0.04 (-1.27%)

VERO Quote, Performance and Key Statistics

VENUS CONCEPT INC

NASDAQ:VERO (3/4/2025, 5:43:26 PM)

After market: 3.11 -0.04 (-1.27%)

3.15

+2.87 (+1025%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.43
52 Week Low0.25
Market Cap22.87M
Shares7.26M
Float6.75M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-31 2025-03-31/amc
IPO10-12 2017-10-12


VERO short term performance overview.The bars show the price performance of VERO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 200 400 600 800

VERO long term performance overview.The bars show the price performance of VERO in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 100 200

The current stock price of VERO is 3.15 USD. In the past month the price increased by 837.5%. In the past year, price increased by 275%.

VENUS CONCEPT INC / VERO Daily stock chart

VERO Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 29.46 238.63B
ISRG INTUITIVE SURGICAL INC 76.12 199.00B
BSX BOSTON SCIENTIFIC CORP 41.28 152.70B
SYK STRYKER CORP 31.99 148.65B
MDT MEDTRONIC PLC 17.42 119.29B
BDX BECTON DICKINSON AND CO 16.12 64.40B
EW EDWARDS LIFESCIENCES CORP 27.24 42.10B
GEHC GE HEALTHCARE TECHNOLOGY 18.78 38.52B
IDXX IDEXX LABORATORIES INC 39.25 36.16B
RMD RESMED INC 26.19 34.00B
DXCM DEXCOM INC 49.95 32.19B
PHG KONINKLIJKE PHILIPS NVR- NY 18.18 24.96B

About VERO

Company Profile

VERO logo image Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 304 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and 10 direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Company Info

VENUS CONCEPT INC

235 Yorkland Blvd Suite 900

TORONTO ONTARIO M2J 4Y8 CA

CEO: Domenic Serafino

Employees: 304

Company Website: https://www.venusconcept.com/en-uk/

Investor Relations: http://www.ir.venusconcept.com

Phone: 18778488430

VENUS CONCEPT INC / VERO FAQ

What is the stock price of VENUS CONCEPT INC today?

The current stock price of VERO is 3.15 USD. The price increased by 1025% in the last trading session.


What is the ticker symbol for VENUS CONCEPT INC stock?

The exchange symbol of VENUS CONCEPT INC is VERO and it is listed on the Nasdaq exchange.


On which exchange is VERO stock listed?

VERO stock is listed on the Nasdaq exchange.


What is VENUS CONCEPT INC worth?

VENUS CONCEPT INC (VERO) has a market capitalization of 22.87M USD. This makes VERO a Nano Cap stock.


How many employees does VENUS CONCEPT INC have?

VENUS CONCEPT INC (VERO) currently has 304 employees.


Is VENUS CONCEPT INC (VERO) expected to grow?

The Revenue of VENUS CONCEPT INC (VERO) is expected to decline by -18.14% in the next year. Check the estimates tab for more information on the VERO EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy VENUS CONCEPT INC (VERO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VENUS CONCEPT INC (VERO) stock pay dividends?

VERO does not pay a dividend.


When does VENUS CONCEPT INC (VERO) report earnings?

VENUS CONCEPT INC (VERO) will report earnings on 2025-03-31, after the market close.


What is the Price/Earnings (PE) ratio of VENUS CONCEPT INC (VERO)?

VENUS CONCEPT INC (VERO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.02).


What is the Short Interest ratio of VENUS CONCEPT INC (VERO) stock?

The outstanding short interest for VENUS CONCEPT INC (VERO) is 0.01% of its float. Check the ownership tab for more information on the VERO short interest.


VERO Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to VERO. When comparing the yearly performance of all stocks, VERO is one of the better performing stocks in the market, outperforming 99.94% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

VERO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to VERO. Both the profitability and financial health of VERO have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VERO Financial Highlights

Over the last trailing twelve months VERO reported a non-GAAP Earnings per Share(EPS) of -8.02. The EPS decreased by -15.56% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -69.38%
ROE -496.11%
Debt/Equity 3.4
Chartmill High Growth Momentum
EPS Q2Q%21.95%
Sales Q2Q%-14.81%
EPS 1Y (TTM)-15.56%
Revenue 1Y (TTM)-18.57%

VERO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 46% to VERO. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of -1.78% and a revenue growth -18.14% for VERO


Ownership
Inst Owners27.79%
Ins Owners1.96%
Short Float %0.01%
Short Ratio0
Analysts
Analysts45.71
Price TargetN/A
EPS Next Y-1.78%
Revenue Next Year-18.14%